Skip to content
joyce_van_den_broeck_pict

Affiliation

Materialise - Technical Product Manager

Country

Belgium

1. Current Status, Position

Joyce Van den Broeck is currently Technical Product Manager at Materialise. She is responsible for the R&D activities for the personalized orthopaedic implants and instruments for corrective osteotomies.

2. Education

Joyce Van den Broeck studied civil engineering at KU Leuven, master in Biomedical Technology. She obtained a PhD in 2009 for her work on computational modelling for the design of patient-specific instrumentation for orthopaedic surgery.

3. Research Area

Joyce Van den Broeck’s work focuses on the R&D, operational and regulatory activities required to bring personalized implants and instruments for orthopaedic surgery from 3D medical images to the OR.

4. Conflict of interest

No conflict of interest declared.

×

Join us in Prague at the special rate of
350 Euro*(+ 21% Czech VAT)
to promote
WORLD PHARMACIST DAY 2025!

Secure your spot (only 45 seats available!)

*instead of 400 Euro – Offer available from 25/09 at 00h01 to 30/09 at 23h59 CET

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.